3.2.1 Producing Monoclonal Antibodies HT

In this lesson, we will explore the process of producing monoclonal antibodies. Monoclonal antibodies are highly specific antibodies that can target a particular chemical or specific cells in the body. We will discuss how monoclonal antibodies are generated using hybridoma technology, which involves combining mouse lymphocytes and tumour cells to produce a specialised cell called a hybridoma. These hybridoma cells can divide and produce large quantities of identical antibodies.

Production of Monoclonal Antibodies

Monoclonal antibodies are derived from a single clone of cells, ensuring consistency and specificity. They target a specific binding site on a protein antigen, allowing them to recognise and bind to specific molecules or cells.

Hybridoma Technology:

• Stimulation of Mouse Lymphocytes: Mouse lymphocytes are stimulated to produce a particular antibody of interest.
• Hybridoma Cell Formation: The stimulated lymphocytes are fused with a specific type of tumour cell to create a hybridoma cell.
• Properties of Hybridoma Cells: The hybridoma cell possesses the ability to divide and produce the desired antibody.

Cloning of Hybridoma Cells:

• Single Hybridoma Cell Cloning: Individual hybridoma cells are isolated and cloned to produce a large population of identical cells.
• Uniform Antibody Production: Cloning ensures that all the cells produce the same antibody, maintaining consistency and specificity.

Collection and Purification:

• Antibody Harvesting: The monoclonal antibodies produced by the cloned hybridoma cells are collected.
• Purification: The collected antibodies undergo purification processes to remove impurities and contaminants.
• Yielding Large Quantities: The production process results in a significant amount of purified monoclonal antibodies.

Conclusion

The production of monoclonal antibodies involves the generation of a single clone of cells, known as hybridoma cells, which can produce large quantities of identical antibodies. By combining mouse lymphocytes and tumour cells, hybridoma technology allows for the targeted production of specific antibodies. The cloned hybridoma cells ensure consistency in antibody production, enabling the antibodies to target a particular chemical or specific cells in the body. Monoclonal antibodies have revolutionised the field of medicine, offering precise and targeted therapies for various diseases, including cancer, autoimmune disorders, and infectious diseases.